Endocyte, Inc. (ECYT) Tops Q4 EPS by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $200 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
• SuperCom (SPCB) Tops Q3 EPS by 43c